Structure of the homodimeric androgen receptor ligand-binding domain
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The androgen receptor (AR) plays a crucial role in normal physiology, development and metabolism as well as in the aetiology and treatment of diverse pathologies such as androgen insensitivity syndromes (AIS), male infertility and prostate cancer (PCa). Here we show that dimerization of AR ligand-binding domain (LBD) is induced by receptor agonists but not by antagonists. The 2.15-Å crystal structure of homodimeric, agonist- and coactivator peptide-bound AR-LBD unveils a 1,000-Å 2 large dimerization surface, which harbours over 40 previously unexplained AIS- and PCa-associated point mutations. An AIS mutation in the self-association interface (P767A) disrupts dimer formation in vivo , and has a detrimental effect on the transactivating properties of full-length AR, despite retained hormone-binding capacity. The conservation of essential residues suggests that the unveiled dimerization mechanism might be shared by other nuclear receptors. Our work defines AR-LBD homodimerization as an essential step in the proper functioning of this important transcription factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A symmetric dimeric AR LBD structure was also solved recently (Nadal et al., 2017), suggesting that AR may form a dimer similar to the way ERα dimerizes.”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Nadal et al., 2017
Experimental — accuracy not yet measuredIn the citing paper
“the Entrenched state is the most compact, exhibiting the best fit for the X-ray structure of a LBD dimer (Nadal et al., 2017), whereas the extended conformation in the Divorced state deviates the most”
From Allosteric interactions prime androgen receptor dimerization and activation (2022) · cites this paper as Nadal et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Nuclear Receptors, RXR, and the Big Bang
Evans, R. M., & Mangelsdorf, D. J. (2014) · Cell · doi:10.1016/j.cell.2014.03.012 · Cited by 1,200
Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
Allostery in Disease and in Drug Discovery
Nussinov, R., & Tsai, C.-J. (2013) · Cell · doi:10.1016/j.cell.2013.03.034 · Cited by 761
Crystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains
Tanenbaum, D. M., Wang, Y., Williams, S. P., & Sigler, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5998 · Cited by 738
CUPSAT: prediction of protein stability upon point mutations
Parthiban, V., Gromiha, M. M., & Schomburg, D. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl190 · Cited by 695
Atomic structure of progesterone complexed with its receptor
Williams, S. P., & Sigler, P. B. (1998) · Nature · doi:10.1038/30775 · Cited by 659
Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004571200 · Cited by 608
Androgen insensitivity syndrome
Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60071-3 · Cited by 553
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Huang, P., Chandra, V., & Rastinejad, F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135917 · Cited by 533
The androgen receptor gene mutations database: 2012 update
Gottlieb, B., Beitel, L. K., Nadarajah, A., Paliouras, M., & Trifiro, M. (2012) · Human Mutation · doi:10.1002/humu.22046 · Cited by 512
Sack, J. S., Kish, K. F., Wang, C., Attar, R. M., Kiefer, S. E., An, Y., Wu, G. Y., Scheffler, J. E., Salvati, M. E., Krystek, S. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081565498 · Cited by 491
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
Bohl, C. E., Gao, W., Miller, D. D., Bell, C. E., & Dalton, J. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500381102 · Cited by 421
Crystal Structure of a Heterodimeric Complex of RAR and RXR Ligand-Binding Domains
Bourguet, W., Vivat, V., Wurtz, J.-M., Chambon, P., Gronemeyer, H., & Moras, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80424-4 · Cited by 403
Structural basis of androgen receptor binding to selective androgen response elements
Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400
Self-citationAllosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Self-citationStructural Determinants of Allosteric Ligand Activation in RXR Heterodimers
Shulman, A. I., Larson, C., Mangelsdorf, D. J., & Ranganathan, R. (2004) · Cell · doi:10.1016/s0092-8674(04)00119-9 · Cited by 317
A surface on the androgen receptor that allosterically regulates coactivator binding
Estébanez-Perpiñá, E., Arnold, L. A., Nguyen, P., Rodrigues, E. D., Mar, E., Bateman, R., Pallai, P., Shokat, K. M., Baxter, J. D., Guy, R. K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708036104 · Cited by 307
Self-citationGenotype Versus Phenotype in Families with Androgen Insensitivity Syndrome
Boehmer, A. L. M., Brüggenwirth, H., van Assendelft, C., Otten, B. J., Verleun-Mooijman, M. C. T., Niermeijer, M. F., Brunner, H. G., Rouwé, C. W., Waelkens, J. J., Oostdijk, W., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7825 · Cited by 290
Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer
Langley, E., Zhou, Z.-X., & Wilson, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29983 · Cited by 280
iStable: off-the-shelf predictor integration for predicting protein stability changes
Chen, C.-W., Lin, J., & Chu, Y.-W. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s2-s5 · Cited by 235
Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA
Orlov, I., Rochel, N., Moras, D., & Klaholz, B. P. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.445 · Cited by 218
Understanding nuclear receptor form and function using structural biology
Rastinejad, F., Huang, P., Chandra, V., & Khorasanizadeh, S. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0173 · Cited by 207
Rochel, N., Ciesielski, F., Godet, J., Moman, E., Roessle, M., Peluso-Iltis, C., Moulin, M., Haertlein, M., Callow, P., Mély, Y., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2054 · Cited by 193
Structure of a Biologically Active Estrogen Receptor-Coactivator Complex on DNA
Yi, P., Wang, Z., Feng, Q., Pintilie, G. D., Foulds, C. E., Lanz, R. B., Ludtke, S. J., Schmid, M. F., Chiu, W., & O’Malley, B. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.025 · Cited by 184
Compartmentalization of androgen receptor protein–protein interactions in living cells
van Royen, M. E., Cunha, S. M., Brink, M. C., Mattern, K. A., Nigg, A. L., Dubbink, H. J., Verschure, P. J., Trapman, J., & Houtsmuller, A. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609178 · Cited by 170
Self-citationThe Rules of DNA Recognition by the Androgen Receptor
Denayer, S., Helsen, C., Thorrez, L., Haelens, A., & Claessens, F. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0310 · Cited by 169
Self-citationEstébanez-Perpiñá, E., Moore, J. M. R., Mar, E., Delgado-Rodrigues, E., Nguyen, P., Baxter, J. D., Buehrer, B. M., Webb, P., Fletterick, R. J., & Guy, R. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407046200 · Cited by 164
Self-citationThe glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals
Watson, L. C., Kuchenbecker, K. M., Schiller, B. J., Gross, J. D., Pufall, M. A., & Yamamoto, K. R. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2595 · Cited by 163
Haelens, A., Tanner, T., Denayer, S., Callewaert, L., & Claessens, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1701 · Cited by 153
Self-citationVivat, V., Zechel, C., Wurtz, J., Bourguet, W., Kagechika, H., Umemiya, H., Shudo, K., Moras, D., Gronemeyer, H., & Chambon, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5697 · Cited by 150
Functional analysis of 44 mutant androgen receptors from human prostate cancer.
Shi, X., Ma, A., Xia, L. P., Kung, H.-J., & White, R. D. (2002) · PubMed · Cited by 148
Stepwise androgen receptor dimerization
van Royen, M. E., van Cappellen, W. A., de Vos, C., Houtsmuller, A. B., & Trapman, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.096792 · Cited by 143
Self-citationBioinformatics analysis of the epitope regions for norovirus capsid protein
Chen, L., Wu, D., Ji, L., Wu, X., Xu, D., Cao, Z., & Han, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s4-s5 · Cited by 93
Nuclear receptor full-length architectures: confronting myth and illusion with high resolution
Rastinejad, F., Ollendorff, V., & Polikarpov, I. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.10.011 · Cited by 93
AR function in promoting metastatic prostate cancer
Augello, M. A., Den, R. B., & Knudsen, K. E. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9471-3 · Cited by 93
Hay, C. W., & McEwan, I. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032514 · Cited by 74
Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces
Grosdidier, S., Carbó, L. R., Buzón, V., Brooke, G., Nguyen, P., Baxter, J. D., Bevan, C., Webb, P., Estébanez-Perpiñá, E., & Fernández-Recio, J. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1281 · Cited by 69
Self-citationYue, L., Ye, F., Gui, C., Luo, H., Cai, J., Shen, J., Chen, K., Shen, X., & Jiang, H. (2005) · Protein Science · doi:10.1110/ps.04951405 · Cited by 68
Estébanez-Perpiñá, E., Arnold, L. A., Jouravel, N., Togashi, M., Blethrow, J., Mar, E., Nguyen, P., Phillips, K. J., Baxter, J. D., Webb, P., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0174 · Cited by 66
Self-citationvan de Wijngaart, D. J., van Royen, M. E., Hersmus, R., Pike, A. C. W., Houtsmuller, A. B., Jenster, G., Trapman, J., & Dubbink, H. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602567200 · Cited by 66
Self-citationEvidence for DNA-Binding Domain–Ligand-Binding Domain Communications in the Androgen Receptor
Helsen, C., Dubois, V., Verfaillie, A., Young, J., Trekels, M., Vancraenenbroeck, R., De Maeyer, M., & Claessens, F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00151-12 · Cited by 63
Self-citationModulation of nuclear receptor activity by the F domain
Patel, S. R., & Skafar, D. F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.07.009 · Cited by 54
The Activating Enzyme of NEDD8 Inhibits Steroid Receptor Function
Fan, M., Long, X., Bailey, J. A., Reed, C. A., Osborne, E., Gize, E. A., Kirk, E. A., Bigsby, R. M., & Nephew, K. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.2.0778 · Cited by 50
Differential Modulation of Androgen Receptor Action by Deoxyribonucleic Acid Response Elements
Geserick, C., Meyer, H.-A., Barbulescu, K., & Haendler, B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0379 · Cited by 44
Karnik, A., Karnik, R., & Grefen, C. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-105 · Cited by 42
Kinetic analysis of estrogen receptor homo- and heterodimerization in vitro
Jisa, E., & Jungbauer, A. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00023-2 · Cited by 35
Bernardes, A., Batista, F. A. H., Neto, M. D. O., Figueira, A. C. M., Webb, P., Saidemberg, D. M., Palma, M. S., & Polikarpov, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031852 · Cited by 33
FRAP and FRET Methods to Study Nuclear Receptors in Living Cells
van Royen, M. E., Dinant, C., Farla, P., Trapman, J., & Houtsmuller, A. B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-575-0_5 · Cited by 29
Self-citationAllosteric mechanisms of nuclear receptors: insights from computational simulations
Mackinnon, J. A. G., Gallastegui, N., Osguthorpe, D. J., Hagler, A. T., & Estébanez‐Perpiñá, E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.017 · Cited by 28
Self-citationFolding RaCe: a robust method for predicting changes in protein folding rates upon point mutations
Chaudhary, P., Naganathan, A. N., & Gromiha, M. M. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv091 · Cited by 27
Elhaji, Y. A., Wu, J. H., Gottlieb, B., Beitel, L. K., Alvarado, C., Batist, G., & Trifiro, M. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0023 · Cited by 24
Belorusova, A. Y., Ősz, J., Petoukhov, M. V., Peluso‐Iltis, C., Kieffer, B., Svergun, D. I., & Rochel, N. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01122 · Cited by 22
Murono, K., Mendonca, B. B., Arnhold, I. J. P., Rigon, A. C. M. M., Migeon, C. J., & Brown, T. R. (1995) · Human Mutation · doi:10.1002/humu.1380060208 · Cited by 18
Structure–function relationships in nuclear receptors: the facts
Moras, D., Billas, I. M. L., Rochel, N., & Klaholz, B. P. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.009 · Cited by 17
Molecular basis for dimer formation of TRβ variant D355R
Jouravel, N., Sablin, E. P., Togashi, M., Baxter, J. D., Webb, P., & Fletterick, R. J. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22225 · Cited by 11
Cited by
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Nevedomskaya, E., Baumgart, S. J., & Haendler, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051359 · Cited by 254
“In the cell nucleus, the dimerized AR recognizes cognate DNA response elements in regulatory regions located in proximal or more distal intra- and intergenic regions of androgen target genes [4,5].”
BackgroundStructural underpinnings of oestrogen receptor mutations in endocrine therapy resistance
Katzenellenbogen, J. A., Mayne, C. G., Katzenellenbogen, B. S., Greene, G. L., & Chandarlapaty, S. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0001-z · Cited by 216
Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation
De Bosscher, K., Desmet, S. J., Clarisse, D., Estébanez-Perpiña, E., & Brunsveld, L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0349-5 · Cited by 199
Self-citationAndrogen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
Feng, Q., & He, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00858 · Cited by 193
“SRC, steroid receptor coactivator; ARA, AR-associated protein; AF1, activation function 1; AF2, activation function 2, a hydrophobic cleft in the LBD; ARE, androgen response element; DBD, DNA binding domain; LBD, ligand binding domain.”
BackgroundInfluentialAndrogen insensitivity syndrome: a review
Batista, R. L., Costa, E. M. F., Rodrigues, A. D. S., Gomes, N. L., Faria, J. A., Nishi, M. Y., Arnhold, I. J. P., Domenice, S., & Mendonca, B. B. D. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000031 · Cited by 186
Metadata
- Authors
- Nadal, M., Prekovic, S., Gallastegui, N., Helsen, C., Abella, M., Zielinska, K., Gay, M., Vilaseca, M., Taulès, M., Houtsmuller, A. B., van Royen, M. E., Claessens, F., Fuentes-Prior, P., & Estébanez-Perpiñá, E.
- Affiliations
- Agència de Gestió d'Ajuts Universitaris i de Recerca (ES)
- KU Leuven (BE)
- Institute for Research in Biomedicine (ES)
- Erasmus MC (NL)
- ORCID
- Venue
- Nature Communications
- Published
- 2017-02-06
- Volume
- 8
- Issue
- 1
- Pages
- 14388-14388
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5303882
- OpenAlex
- W2586987557
- Cited by
- 193
- References
- 59
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 30 · 2023: 21 · 2022: 22 · 2021: 32 · 2020: 21 · 2019: 13 · 2018: 17 · 2017: 5
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- Lirias (submittedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Generalitat de Catalunya
- Fonds Wetenschappelijk Onderzoek (G068412N, GOA/15/017, G083013N)
- KU Leuven (GOA/15/017)
- Kom op tegen Kanker
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- androgen receptor, ligand-binding domain, homodimerization, crystal structure, coactivator peptide, androgen insensitivity syndrome, prostate cancer, point mutations, transcriptional activation, nuclear receptors, transcription factors
- MeSH terms
- Protein Domains, Androgens, Animals, Chlorocebus aethiops, Humans, Ligands, Male, Models, Molecular, Prostatic Neoplasms, Receptors, Androgen, Androgen-Insensitivity Syndrome, Point Mutation, Crystallography, X-Ray, COS Cells, Surface Plasmon Resonance, Protein Structure, Quaternary, Ubiquitin-Activating Enzymes, Cell Line, Tumor, Protein Multimerization, Androgen Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.